HIT Consultant – Read More

What You Should Know

– Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs).

– By combining virtual, whole-person clinical care with transparent “cash-price” subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to GLP-1s and other AOMs.

Bypassing the PBM “Walled Garden”

The Vida Self-Pay model functions as a flexible “first line of defense” alongside traditional insurance benefits.

• Transparent Cash Pricing: The platform connects employees directly to transparent, cash-priced prescriptions, bypassing the opaque markups of traditional Pharmacy Benefit Managers (PBMs).
• Defined Contribution Subsidies: Employers support eligible employees through a fixed monthly contribution toward self-pay pricing. This allows the employer to subsidize a portion of the drug cost directly without adding high-cost GLP-1s to their official formulary.
• A “Payment Bridge”: RxSaveCard provides the essential mechanism that links employer contributions to competitive self-pay platforms, ensuring employees access the best market pricing.

Predictable ROI in a Volatile Market

For CFOs and HR leaders, the most compelling part of this announcement isn’t just the clinical outcome—it’s the predictability. By utilizing a defined contribution model, organizations can support employee health goals without the open-ended financial risk typically associated with GLP-1 formulary coverage. This is “Value-Based Care” in its most practical form: putting outcomes at the center while managing unit cost through innovative payment rails.